BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26671553)

  • 1. The role of microRNAs in the adrenocortical carcinomas.
    Yu X; Li Z
    Tumour Biol; 2016 Feb; 37(2):1515-9. PubMed ID: 26671553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
    Özata DM; Caramuta S; Velázquez-Fernández D; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui WO
    Endocr Relat Cancer; 2011 Oct; 18(6):643-55. PubMed ID: 21859927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.
    Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P
    Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma - A focus on signaling pathways interplay.
    Midan HM; Helal GK; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Elballal MS; Zaki MB; Abd-Elmawla MA; Al-Noshokaty TM; Rizk NI; Elrebehy MA; El-Dakroury WA; Hashem AH; Doghish AS
    Pathol Res Pract; 2023 Aug; 248():154690. PubMed ID: 37473498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance.
    El-Dakroury WA; Midan HM; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Elballal MS; Zaki MB; Abd-Elmawla MA; Al-Noshokaty TM; Rizk NI; Elrebehy MA; Hashem AH; Moustafa YM; Doghish AS
    Pathol Res Pract; 2023 Aug; 248():154665. PubMed ID: 37418996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
    Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
    Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.
    Schmitz KJ; Helwig J; Bertram S; Sheu SY; Suttorp AC; Seggewiss J; Willscher E; Walz MK; Worm K; Schmid KW
    J Clin Pathol; 2011 Jun; 64(6):529-35. PubMed ID: 21471143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of microRNAs in adrenocortical tumors.
    Singh P; Soon PS; Feige JJ; Chabre O; Zhao JT; Cherradi N; Lalli E; Sidhu SB
    Mol Cell Endocrinol; 2012 Mar; 351(1):118-28. PubMed ID: 21996374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.
    Glover AR; Zhao JT; Gill AJ; Weiss J; Mugridge N; Kim E; Feeney AL; Ip JC; Reid G; Clarke S; Soon PS; Robinson BG; Brahmbhatt H; MacDiarmid JA; Sidhu SB
    Oncotarget; 2015 Nov; 6(34):36675-88. PubMed ID: 26452132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.
    Detomas M; Pivonello C; Pellegrini B; Landwehr LS; Sbiera S; Pivonello R; Ronchi CL; Colao A; Altieri B; De Martino MC
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.
    Caramuta S; Lee L; Ozata DM; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui WO
    Endocr Relat Cancer; 2013 Aug; 20(4):551-64. PubMed ID: 23671264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.
    Patel D; Boufraqech M; Jain M; Zhang L; He M; Gesuwan K; Gulati N; Nilubol N; Fojo T; Kebebew E
    Surgery; 2013 Dec; 154(6):1224-8; discussion 1229. PubMed ID: 24238045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circulating microRNAs in adrenocortical tumors.
    Szabó DR; Luconi M; Szabó PM; Tóth M; Szücs N; Horányi J; Nagy Z; Mannelli M; Patócs A; Rácz K; Igaz P
    Lab Invest; 2014 Mar; 94(3):331-9. PubMed ID: 24336071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.
    Faria AM; Sbiera S; Ribeiro TC; Soares IC; Mariani BM; Freire DS; de Sousa GR; Lerario AM; Ronchi CL; Deutschbein T; Wakamatsu A; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Fassnacht M; Almeida MQ
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):481-8. PubMed ID: 25200669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.
    Chabre O; Libé R; Assie G; Barreau O; Bertherat J; Bertagna X; Feige JJ; Cherradi N
    Endocr Relat Cancer; 2013 Aug; 20(4):579-94. PubMed ID: 23756429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.
    Koperski Ł; Kotlarek M; Świerniak M; Kolanowska M; Kubiak A; Górnicka B; Jażdżewski K; Wójcicka A
    Oncotarget; 2017 Jul; 8(30):49191-49200. PubMed ID: 28423361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenic and diagnostic roles of microRNAs in adrenocortical tumours].
    Nagy Z; Decmann Á; Perge P; Igaz P
    Orv Hetil; 2018 Feb; 159(7):245-251. PubMed ID: 29429354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines.
    Li SC; Monazzam A; Razmara M; Chu X; Stålberg P; Skogseid B
    Sci Rep; 2021 Jul; 11(1):14772. PubMed ID: 34285285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review.
    Xu C; Xu P; Zhang J; He S; Hua T; Huang A
    Medicine (Baltimore); 2024 Jan; 103(4):e36908. PubMed ID: 38277554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.